Krystal Biotech, Inc.
KRYS
$143.96
-$2.34-1.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.87% | 14.60% | 12.28% | 4.67% | 17.19% |
| Total Receivables | 7.95% | 122.22% | 149.16% | 944.42% | -- |
| Inventory | 154.87% | 171.29% | 279.50% | 252.05% | -- |
| Prepaid Expenses | 117.96% | 158.29% | 97.94% | 63.97% | 19.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.23% | 27.32% | 26.22% | 22.51% | 41.07% |
|
|
|||||
| Total Current Assets | 23.23% | 27.32% | 26.22% | 22.51% | 41.07% |
| Net Property, Plant & Equipment | -4.49% | -4.75% | -4.03% | -4.86% | -3.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.35% | 11.22% | -12.17% | -28.77% | -55.79% |
| Total Assets | 24.05% | 25.91% | 29.02% | 24.29% | 34.16% |
|
|
|||||
| Total Accounts Payable | 31.32% | -50.14% | 20.64% | 28.57% | 22.02% |
| Total Accrued Expenses | 110.19% | 224.75% | 190.82% | 269.70% | 225.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.81% | -4.76% | -17.44% | -13.92% | -10.99% |
| Total Finance Division Other Current Liabilities | -65.50% | -28.30% | 360.53% | 292.41% | 307.19% |
| Total Other Current Liabilities | -65.50% | -28.30% | 360.53% | 292.41% | 307.19% |
| Total Current Liabilities | 20.94% | 67.03% | 208.20% | 224.57% | 200.66% |
|
|
|||||
| Total Current Liabilities | 20.94% | 67.03% | 208.20% | 224.57% | 200.66% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.47% | 28.38% | -8.70% | -9.31% | -9.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 373.98% | -- | -- | -- | -- |
| Total Liabilities | 24.10% | 66.02% | 175.62% | 180.43% | 154.80% |
|
|
|||||
| Common Stock & APIC | 4.87% | 5.69% | 7.58% | 7.31% | 7.92% |
| Retained Earnings | 57.92% | 46.10% | 33.04% | 18.80% | 29.49% |
| Treasury Stock & Other | 282.49% | 230.43% | -129.78% | 495.81% | -168.64% |
| Total Common Equity | 24.05% | 23.20% | 21.54% | 17.18% | 28.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.05% | 23.20% | 21.54% | 17.18% | 28.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.05% | 23.20% | 21.54% | 17.18% | 28.45% |
|
|
|||||